Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Follicular × temsirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 13 Neoplasm Metastasis 11 Glioblastoma 7 Prostatic Neoplasms 6 Neoplasms 6 Kidney Neoplasms 6 Brain Neoplasms 6 Sarcoma 5 Carcinoma, Hepatocellular 5 Ovarian Neoplasms 4 Glioma 4 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Oligodendroglioma 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Liver Neoplasms 3 Colorectal Neoplasms 3 Astrocytoma 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2

Interventions

Cyclophosphamide 161 Rituximab 148 fludarabine phosphate 84 Peripheral Blood Stem Cell Transplantation 79 Filgrastim 65 Etoposide 59 Radiotherapy 57 Mycophenolic Acid 54 Whole-Body Irradiation 53 Cyclosporine 44 Lenalidomide 42 Melphalan 40 Tacrolimus 39 Busulfan 38 Prednisone 35 fludarabine 34 Vincristine 34 Antilymphocyte Serum 33 Cytarabine 31 Bendamustine Hydrochloride 29 obinutuzumab 28 Methotrexate 28 Doxorubicin 28 Carmustine 26 Methylprednisolone 23 ibritumomab tiuxetan 22 Cord Blood Stem Cell Transplantation 22 Dexamethasone 21 sargramostim 20 Bortezomib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01078142 2017-09-11

BERT

Johannes Gutenberg University Mainz

Phase 1/2 Completed

Lymphoma, Follicular, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡